HIV-Positive Patients with Lymphoma Should No Longer Be Excluded from ...

Results from the clinical trial, presented at the American Society of Hematology meetings on December 8 at 4:45 p.m. PST, show the concern of additional risk is unfounded. Patients with HIV-associated lymphoma who meet standard eligibility criteria should receive an autologous blood stem cell transplant as standard of care or be enrolled in a National Institutes of Health -funded clinical trial.

http://ift.tt/1ADteWv